Literature DB >> 29987772

Gender and Race Disparities in Cardiovascular Disease Risk Factors among New York City Adults: New York City Health and Nutrition Examination Survey (NYC HANES) 2013-2014.

Rania Kanchi1, Sharon E Perlman2, Claudia Chernov2, Winfred Wu2, Bahman P Tabaei2, Chau Trinh-Shevrin3, Nadia Islam3, Azizi Seixas3, Jesica Rodriguez-Lopez4, Lorna E Thorpe3.   

Abstract

While gender and racial/ethnic disparities in cardiovascular disease (CVD) risk factors have each been well characterized, few studies have comprehensively examined how patterns of major CVD risk factors vary and intersect across gender and major racial/ethnic groups, considered together. Using data from New York City Health and Nutrition Examination Survey 2013-2014-a population-based, cross-sectional survey of NYC residents ages 20 years and older-we measured prevalence of obesity, hypertension, hypercholesterolemia, smoking, and diabetes across gender and race/ethnicity groups for 1527 individuals. We used logistic regression with predicted marginal to estimate age-adjusted prevalence ratio by gender and race/ethnicity groups and assess for potential additive and multiplicative interaction. Overall, women had lower prevalence of CVD risk factors than men, with less hypertension (p = 0.040), lower triglycerides (p < 0.001), higher HDL (p < 0.001), and a greater likelihood of a heart healthy lifestyle, more likely not to smoke and to follow a healthy diet (p < 0.05). When further stratified by race/ethnicity, however, the female advantage was largely restricted to non-Latino white women. Non-Latino black women had significantly higher risk of being overweight or obese, having hypertension, and having diabetes than non-Latino white men or women, or than non-Latino black men (p < 0.05). Non-Latino black women also had higher total cholesterol compared to non-Latino black men (184.4 vs 170.5 mg/dL, p = 0.010). Despite efforts to improve cardiovascular health and narrow disparities, non-Latino black women continue to have a higher burden of CVD risk factors than other gender and racial/ethnic groups. This study highlights the importance of assessing for intersectionality between gender and race/ethnicity groups when examining CVD risk factors.

Entities:  

Keywords:  Cardiovascular disease; Disparities; Gender; Intersectionality; NYC HANES; Race

Mesh:

Year:  2018        PMID: 29987772      PMCID: PMC6286284          DOI: 10.1007/s11524-018-0287-x

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  41 in total

Review 1.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Authors:  Rachel Huxley; Federica Barzi; Mark Woodward
Journal:  BMJ       Date:  2005-12-21

2.  Environment, obesity, and cardiovascular disease risk in low-income women.

Authors:  Lee R Mobley; Elisabeth D Root; Eric A Finkelstein; Olga Khavjou; Rosanne P Farris; Julie C Will
Journal:  Am J Prev Med       Date:  2006-04       Impact factor: 5.043

3.  Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.

Authors:  Gayle S Bieler; G Gordon Brown; Rick L Williams; Donna J Brogan
Journal:  Am J Epidemiol       Date:  2010-02-04       Impact factor: 4.897

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

5.  Age at natural menopause and risk of cardiovascular disease.

Authors:  F B Hu; F Grodstein; C H Hennekens; G A Colditz; M Johnson; J E Manson; B Rosner; M J Stampfer
Journal:  Arch Intern Med       Date:  1999-05-24

6.  Life course SES and cardiovascular risk: Heterogeneity across race/ethnicity and gender.

Authors:  Katrina M Walsemann; Bridget J Goosby; Deeonna Farr
Journal:  Soc Sci Med       Date:  2016-01-26       Impact factor: 4.634

7.  Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006.

Authors:  Carla I Mercado; Quanhe Yang; Earl S Ford; Edward Gregg; Amy L Valderrama
Journal:  Obesity (Silver Spring)       Date:  2015-09       Impact factor: 5.002

Review 8.  Obesity in Hispanic Americans.

Authors:  M Z Nichaman; G Garcia
Journal:  Diabetes Care       Date:  1991-07       Impact factor: 19.112

9.  Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults.

Authors:  Camila X Romero; Tomas E Romero; Judith C Shlay; Lorraine G Ogden; Dana Dabelea
Journal:  Adv Prev Med       Date:  2012-12-02

10.  Rationale, design and respondent characteristics of the 2013-2014 New York City Health and Nutrition Examination Survey (NYC HANES 2013-2014).

Authors:  Lorna E Thorpe; Carolyn Greene; Amy Freeman; Elisabeth Snell; Jesica S Rodriguez-Lopez; Martin Frankel; Amado Punsalang; Claudia Chernov; Elizabeth Lurie; Mark Friedman; Ram Koppaka; Sharon E Perlman
Journal:  Prev Med Rep       Date:  2015-07-02
View more
  16 in total

1.  Calibrating Local Population-Based Blood Pressure Data from NYC HANES 2013-2014.

Authors:  Rania Kanchi; Sharon Perlman; Yechiam Ostchega; Shadi Chamany; Daichi Shimbo; Claudia Chernov; Lorna E Thorpe
Journal:  J Urban Health       Date:  2019-10       Impact factor: 3.671

Review 2.  Neighborhood Environment and DNA Methylation: Implications for Cardiovascular Disease Risk.

Authors:  Carmen Giurgescu; Alexandra L Nowak; Shannon Gillespie; Timiya S Nolan; Cindy M Anderson; Jodi L Ford; Daryl B Hood; Karen Patricia Williams
Journal:  J Urban Health       Date:  2019-03       Impact factor: 3.671

3.  Physiological Significance of Discrimination on Stress Markers, Obesity, and LDL Oxidation among a European American and African American Cohort of Females.

Authors:  Yenni E Cedillo; Rachel O Lomax; Jose R Fernandez; Douglas R Moellering
Journal:  Int J Behav Med       Date:  2020-04

4.  The health and economic impact of the Tobacco 21 Law in El Paso County, Texas: A modeling study.

Authors:  Whitney Garney; Sonya Panjwani; Laura King; Joan Enderle; Dara O'Neil; Yan Li
Journal:  Prev Med Rep       Date:  2022-07-06

Review 5.  Intersectionality in quantitative health disparities research: A systematic review of challenges and limitations in empirical studies.

Authors:  Lexi Harari; Chioun Lee
Journal:  Soc Sci Med       Date:  2021-03-24       Impact factor: 4.634

6.  Racial-ethnic inequality in cardiovascular health in the United States: Does it mirror socioeconomic inequality?

Authors:  Julien Teitler; Bethany M Wood; Weiwen Zeng; Melissa L Martinson; Rayven Plaza; Nancy E Reichman
Journal:  Ann Epidemiol       Date:  2021-05-13       Impact factor: 6.996

7.  Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United States.

Authors:  Yvonne Commodore-Mensah; Ruth-Alma Turkson-Ocran; Kathryn Foti; Lisa A Cooper; Cheryl Dennison Himmelfarb
Journal:  Am J Hypertens       Date:  2021-08-09       Impact factor: 3.080

Review 8.  Sex and gender: modifiers of health, disease, and medicine.

Authors:  Franck Mauvais-Jarvis; Noel Bairey Merz; Peter J Barnes; Roberta D Brinton; Juan-Jesus Carrero; Dawn L DeMeo; Geert J De Vries; C Neill Epperson; Ramaswamy Govindan; Sabra L Klein; Amedeo Lonardo; Pauline M Maki; Louise D McCullough; Vera Regitz-Zagrosek; Judith G Regensteiner; Joshua B Rubin; Kathryn Sandberg; Ayako Suzuki
Journal:  Lancet       Date:  2020-08-22       Impact factor: 79.321

Review 9.  A bibliometric analysis of income and cardiovascular disease: Status, Hotspots, Trends and Outlook.

Authors:  Ye Ding; Dingwan Chen; Xufen Ding; Guan Wang; Yuehua Wan; Qing Shen
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

10.  Prevalence, treatment, and control of severe hyperlipidemia.

Authors:  Matthew E Gold; Michael G Nanna; Shannon M Doerfler; Tony Schibler; Daniel Wojdyla; Eric D Peterson; Ann Marie Navar
Journal:  Am J Prev Cardiol       Date:  2020-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.